Back to Screener

Healthcare

Albireo Pharma, Inc.(ALBO)

Live Price

Offline

$44.15

+0.00% today

1Y Change

Window

No data

Market Cap
$915.89M
Revenue Growth
+388.4%
EPS Growth
-5.6%
Dividend Yield
0.0%
No coverage

Historical coverage is still loading

We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.

No price data

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Albireo Pharma, Inc. (ALBO) is a Healthcare stock with a market cap of $915.89M. The stock last traded around $44.15. Baseline metrics include revenue growth of +388.4%, EPS growth of -5.6%, a dividend yield of 0.0%. What stands out right now is revenue +388.4%, EPS -5.6%, free cash flow -6.8% with operating margin -304.3% and ROIC -48.1%. Valuation already assumes a fairly strong business story at price/sales 22.6. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines ALBO price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

ALBO

Normalized return

SPY

S&P 500

Excess Return

Relative to SPY

ALBO Max Drawdown

Trailing 1Y

SPY Max Drawdown

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for ALBO and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

📅 Last reportedMay 15, 2023
PeriodB/MEPSEPS ΔRevenueRev ΔReport
May 15, 23
Est -1.97
Est 9630.0B
May 15
Mar 7, 23
-0.57
Est -1.80
+68.3%
Est 9880.0B
Mar 7
Nov 8, 22
-1.92
Est -1.06
-81.1%
9832.0B
Est
Nov 8
Aug 15, 22
-2.04
Est -1.65
-23.6%
8206.0B
Est
Aug 15
May 16, 22
-2.19
Est -1.85
-18.4%
6832.0B
Est 5576.4B
+22.5%
May 16
Mar 1, 22
-0.57
Est -1.35
+57.8%
32521.0B
Est 7800.0B
+316.9%
Mar 1
Nov 4, 21
2.90
Est -0.38
+863.2%
3664.0B
Est 3500.0B
+4.7%
Nov 4
Aug 5, 21
-1.90
Est -1.97
+3.5%
2428.0B
Est 2428.0B
0.0%
Aug 5
May 6, 21
-2.29
Est -1.77
-29.4%
1966.0B
Est 1388.4B
+41.6%
May 6
Feb 25, 21
-1.30
Est -1.94
+33.0%
2716.0B
Est 3612.0B
-24.8%
Feb 25
Nov 5, 20
-1.96
Est -1.51
-29.8%
2131.0B
Est 1641.7B
+29.8%
Nov 5
Aug 6, 20
-1.38
Est -1.69
+18.3%
1912.0B
Est 2341.5B
-18.3%
Aug 6
May 7, 20
-2.23
Est -1.36
-64.0%
1549.0B
Est 1381.3B
+12.1%
May 7
Mar 2, 20
-0.57
Est -1.59
+64.2%
6431.0B
Est 17939.1B
-64.2%
Mar 2
Nov 6, 19
-1.73
Est -1.56
-10.9%
1385.0B
Est 1248.9B
+10.9%
Nov 6
Aug 8, 19
-1.35
Est -1.43
+5.6%
1250.0B
Est 1324.1B
-5.6%
Aug 8
May 9, 19
-1.39
Est -1.32
-5.3%
570.0B
Est 541.3B
+5.3%
May 9
Mar 6, 19
-1.34
Est -1.16
-15.5%
12740.0B
Est 494.3B
+2477.4%
Mar 6
Nov 8, 18
-1.17
Est -0.98
-19.4%
237.0B
Est 198.5B
+19.4%
Nov 8
Aug 7, 18
-1.22
Est -0.95
-28.4%
730.0B
Est 568.4B
+28.4%
Aug 7
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.